Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,008 INR | -0.32% | -3.11% | +15.90% |
May. 13 | Glenmark Pharmaceuticals to Acquire 26% Stake in Renewable Energy Company | MT |
May. 03 | Glenmark Pharmaceuticals Limited Appoints Shweta Munjal as Chief Communications & CSR Officer | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.90% | 3.42B | |
+20.92% | 44.4B | |
+24.60% | 23.03B | |
+18.00% | 15.14B | |
+13.18% | 13.12B | |
+44.42% | 11.85B | |
-8.33% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.52B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Transcript : Glenmark Pharmaceuticals Limited, Q4 2020 Earnings Call, Jun 29, 2020